MedPath

白云山汤阴东泰药业有限责任公司

Ownership
-
Established
2004-04-15
Employees
-
Market Cap
-
Website
http://www.bysdt.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

20

NMPA:20

Drug Approvals

Oxytetracycline Tablets

Product Name
土霉素片
Approval Number
国药准字H41020537
Approval Date
Jan 20, 2025
NMPA

Levofloxacin Tablets

Product Name
左氧氟沙星片
Approval Number
国药准字H20249453
Approval Date
Nov 22, 2024
NMPA

Levofloxacin Tablets

Product Name
左氧氟沙星片
Approval Number
国药准字H20249425
Approval Date
Nov 22, 2024
NMPA

Erythromycin Enteric-coated Tablets

Product Name
红霉素肠溶片
Approval Number
国药准字H41020540
Approval Date
Jun 5, 2020
NMPA

Inosine Tablets

Product Name
肌苷片
Approval Number
国药准字H41020536
Approval Date
Jun 5, 2020
NMPA

Furazolidone Tablets

Product Name
呋喃唑酮片
Approval Number
国药准字H41020531
Approval Date
Jun 5, 2020
NMPA

Rifampicin Capsules

Product Name
利福平胶囊
Approval Number
国药准字H41020542
Approval Date
Jun 5, 2020
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H41020534
Approval Date
Jun 5, 2020
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H41020539
Approval Date
Mar 5, 2020
NMPA

Paracetamol,Caffein,Atificial Cow-bezoar and Chlorphenamine Maleate Capsules

Product Name
氨咖黄敏胶囊
Approval Number
国药准字H41024468
Approval Date
Nov 8, 2019
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.